Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy
Authors:
- Hiroaki AkamatsuHAHiroaki Akamatsu
- Keita MoriKMKeita Mori
- Tateaki NaitoTateaki Naito
- Hisao ImaiHIHisao Imai
- Akira OnoAOAkira Ono
- Takehito ShukuyaTSTakehito Shukuya
- Tetsuhiko TairaTTTetsuhiko Taira
- Hirotsugu KenmotsuHKHirotsugu Kenmotsu
- Haruyasu MurakamiHMHaruyasu Murakami
- Masahiro EndoMEMasahiro Endo
- Hideyuki HaradaHHHideyuki Harada
- Toshiaki TakahashiTTToshiaki Takahashi
Open Access
- 14 January 2014
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 18
Abstract
In locally advanced Non-Small-Cell Lung Cancer (LA-NSCLC) patients treated with chemoradiotherapy (CRT), optimal surrogate endpoint for cure has not been fully investigated.Keywords
This publication has 16 references indexed in Scilit:
- S-1 Plus Cisplatin with Concurrent Radiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Multi-Institutional Phase II Trial (West Japan Thoracic Oncology Group 3706)Journal of Thoracic Oncology, 2011
- Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: West Japan Thoracic Oncology Group WJTOG0105Journal of Clinical Oncology, 2010
- Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: OLCSG 0007Journal of Clinical Oncology, 2010
- Concurrent chemoradiotherapy in non-small cell lung cancerCochrane Database of Systematic Reviews, 2010
- Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2010
- Locally Advanced Non-small Cell Lung Cancer: The Past, Present, and FutureJournal of Thoracic Oncology, 2008
- Concurrent Chemoradiotherapy with Cisplatin and Vinorelbine for Stage III Non-small Cell Lung CancerJournal of Thoracic Oncology, 2008
- Phase I study of cisplatin, vinorelbine, and concurrent thoracic radiotherapy for unresectable stage III non‐small cell lung cancerCancer Science, 2004
- Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung CancerChest, 2000
- Radiothérapie du cancer bronchique non à petites cellules de stade III, inopérable, asymptomatique. Résultats définitifs d'un essai prospectif randomisé (240 patients)Cancer/Radiothérapie, 1999